HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NCI

Hormone Replacement Therapy May Improve Survival for Women with Ovarian Cancer

HRT  hormone therapy  estrogen  ovarian cancer  hormone replacement therapy  postmenopausal symptoms  survival  institute for cancer research  adjuvant therapy  women’s health initiative 

The randomized, controlled Adjuvant Hormone Therapy trial was launched in 1990 to assess the effects of estrogen-alone hormone replacement therapy in women treated for epithelial ovarian cancer.

Preview   0 Users liked this content.
NCI

TAILORx Trial Shows Women at Low Risk for Breast Cancer Recurrence May Forgo Chemotherapy

lymphedema  breast cancer  TAILORx  oncotype dx  hormone receptor-positive  recurrence  hormone therapy 

A summary of results from the Trial Assigning Individualized Options for Treatment, or TAILORx, finds that women with early-stage hormone receptor-positive breast cancer have a low risk of recurrence based on a test for the expression of 21 genes.

Preview   0 Users liked this content.
CDC

Prostate Cancer Treatment

cancer  treatment  prostate  chemotherapy  surgery  PSA  Radiation Therapy  hormone therapy  Active surveillance  watchful waiting  Cryotherapy 

Different types of treatment are available for prostate cancer. You and your doctor will decide which treatment is right for you.

Preview   0 Users liked this content.
NCI

Hormone Replacement Therapy May Improve Survival for Women with Ovarian Cancer

HRT  hormone therapy  estrogen  ovarian cancer  hormone replacement therapy  postmenopausal symptoms  survival  institute for cancer research  adjuvant therapy  women’s health initiative  womens health initiative 

The randomized, controlled Adjuvant Hormone Therapy trial was launched in 1990 to assess the effects of estrogen-alone hormone replacement therapy in women treated for epithelial ovarian cancer.

Preview   0 Users liked this content.